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 Abstract 
Background 
To achieve good outcomes in critically ill obstetric patients it is necessary to identify 
organ dysfunction rapidly so that life-saving interventions can be appropriately 
commenced. However, timely access to clinical chemistry results is problematic even 
in referral institutions in the sub Saharan African region. Reliable point of care tests 
licensed for clinical use are now available for lactate and creatinine.  
Aim 
We aimed to assess whether implementation of point of care testing for lactate and 
creatinine is feasible in the obstetric unit at the Queen Elizabeth Central Hospital 
(QECH), Malawi, by obtaining the opinions of clinical staff on the use of these tests in 
practice. 
Methods 
During a two month evaluation period nurse-midwives, medical interns, clinical 
officers, registrars and consultants were given the opportunity to use StatStrip® and 
StatSensor® (Nova Biomedical) devices for lactate and creatinine estimation as part 
of their routine clinical practice in the obstetric unit. They were subsequently asked 
to complete a short questionnaire. 
Results 
37 questionnaire responses were received, 22 from nurse-midwives and the 
remainder from clinicians. The mean satisfaction score for the devices was 7.6/10 
amongst clinicians and 8.0/10 amongst nurse-midwives. The majority of participants 
stated that the obstetric high dependency unit (HDU) was the most suitable location 
for the devices. For lactate, 31 participants strongly agreed that testing should be 
continued and 24 strongly agreed that it would influence patient management. For 
creatinine, 29 strongly agreed that testing should be continued and 28 strongly 
agreed that it would influence their patient management. 20 participants strongly 
agreed that they trust point of care devices.  
Conclusion 
Point of care clinical chemistry testing is feasible, practical, well received by staff and 
was considered by staff to have a useful role to play in the clinical care of very sick 
obstetric patients at this referral centre.  
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Introduction 
 
In the context of obstetric practice, there are difficulties in the early recognition of 
severe sepsis and renal compromise in that patients are relatively young and are 
usually previously healthy, so the development of obvious clinical signs may occur 
only at a very late stage in the evolution of the condition. Thus, organ failure is often 
already established by the time a firm diagnosis is made. Maternal mortality is high 
in QECH with sepsis and pre eclampsia being amongst the most common causes of 
death (1). 
Previous studies in low resource settings reported that point of care devices greatly 
enhanced the feasibility of biochemical tests (2), that they could be used quickly and 
easily by auxiliary health personnel (3), that they were well received by staff and that 
they made a positive contribution to medical care (4). Furthermore, point of care 
testing may enable more efficient use of scarce resources, leading to reduced length 
of hospital stay, fewer unnecessary hospital admissions and reduced use of blood 
products (5). In the local setting there are naturally tremendous challenges with 
regards to cost of laboratory investigations and while point of care devices are in use 
as part of research studies with samples tested by project staff, these have not been 
brought into the routine service setting. Potential difficulties associated with the 
introduction of point of care testing into the clinical setting include logistic problems, 
poor documentation of test results, lack of critical value notification system and poor 
quality control (6). However, these challenges may be overcome by staff training.     
Lactate and creatinine testing is especially valuable for identification of critical illness 
amongst obstetric patients. Hyperlactataemia is common in critically ill patients and 
is thought to arise due to release of catecholamines in shock states (7). Lactate 
predicts mortality in intensive care patients (8) and its use to guide resuscitation 
reduces hospital mortality (9). Creatinine facilitates early detection of pregnancy-
related acute kidney injury, a condition associated with devastating maternal and 
foetal consequences (10). However, serum lactate analysis is not currently offered in 
the QECH whilst creatinine analysis and feedback of results may take up to three 
days via the hospital laboratory.  
The aim of this study was to evaluate whether implementation of point of care 
devices for lactate and creatinine is feasible in the Department of Obstetrics and 
Gynaecology at QECH. The specific objectives were as follows: 
1) To explore staff opinion on whether point of care devices for lactate and 
creatinine are easy to use, influence patient management and whether the 
staff considers that there is potential for future use and sustainability. 
2) To determine which cadre of staff is the most appropriate for handling point 
of care clinical chemistry devices and the most suitable location of the 
devices within the unit, including the obstetric admissions unit, labour ward 
and HDU. 
 
 
Methods 
StatStrip Xpress® lactate meters and StatSensor Xpress® creatinine meters and test 
strips (Nova Biomedical, Waltham, USA), licensed internationally for clinical 
applications, were placed in the Department of Obstetrics and Gynaecology at QECH 
between June and July 2015 as part of a pilot study testing the feasibility of hand-
held point of care devices. Staff were briefed on the correct operation of these 
devices in groups or individually and user information materials were provided 
including normal reference ranges. Staff were encouraged to employ the devices in 
their routine clinical practice where they considered it appropriate for patient care. 
Feasibility of use was explored in different wards of the Department including the 
labour ward, obstetric admissions unit, obstetric HDU and the postnatal ward.  
Creatinine test strips and quality control solutions were stored in the Unit 
refrigerator, lactate strips and solutions were stored at room temperature and 
quality control tests using standard solutions for lactate and creatinine were 
performed regularly according to the product literature.  
After six weeks staff were presented with anonymous, paper-based questionnaires 
comprising 15 items seeking their views on point of care testing for lactate and 
creatinine in the Department. All members of clinical staff employed in the 
department of Obstetrics and Gynaecology at QECH who had used the devices or 
results from them were eligible for participation. Questions focussed on the overall 
satisfaction, perceived ease of use, any difficulties experienced and who the 
respondent considered should be responsible for handling these devices. 
Furthermore, participants were asked to rate whether testing for lactate and 
creatinine was useful, whether it would influence patient management, whether it 
should be continued, whether it would increase efficiency, the type of patients and 
location where it would be most useful and how much they trust results from the 
devices. As serum creatinine analysis is available from the hospital laboratory, 
participants were also asked whether they preferred point of care testing to 
laboratory analysis. The response options were: “strongly agree”, “somewhat agree”, 
“neither agree or disagree”, “somewhat disagree”, “strongly disagree” and “don’t 
know”. Results for overall satisfaction and perceived ease-of-use are presented as 
means and standard deviations (SD).  
Exemption from ethics review was granted by the College of Medicine Research 
Ethics Committee (COMREC) under reference P.04/15/1723; approval was granted 
by the University Teaching and Research Ethics Committee (UTREC) at the University 
of St Andrews under reference MD11557.  
 
 
 
 
 
 
Results 
No member of staff refused to participate. A total of 37 questionnaire responses 
were received; 22 from nurse-midwives, eight from medical interns, three from 
registrars, two from consultants, one from a clinical officer and one from a final year 
medical student. For reporting here, staff other than nurse-midwives are referred to 
as clinicians. Six clinicians had used the devices 1-2 times, two 3-7 times and one 
more than eight times. Among nurse-midwives, five had used the devices 1-2 times, 
five had used them 3-7 times and three had used them more than 8 times. On a 
scale of 0 to 10 where 10 indicated ‘extremely satisfied’, the mean overall score for 
satisfaction with the devices was 7.6 (SD 1.4) amongst clinicians and 8.0 (SD 1.4) 
amongst nurse-midwives. The ease-of-use was rated as a mean 9.1 (SD 1.0) and 9.0 
(SD 1.5) by clinicians and nurse-midwives respectively. Both groups most commonly 
stated that nurse-midwives should mainly be responsible for point of care testing, 
followed by “all members of staff”. Three clinicians had experienced difficulties with 
point of care testing compared to two nurse-midwives. Difficulties mainly related to 
error messages; however, these were almost always due to poor technique during 
early use rather than intrinsic faults of the devices and were resolved and explained 
quickly by the investigators.  
It appeared that two participants had misread the answer options “strongly disagree” 
and “strongly agree” in the second part of the survey, as they had rated the meters 
positively in the first part or commented favourably in the open space questions 
(“They should be enrolled in all central hospitals in Malawi”). The answers of these 
participants were therefore moderated to compensate for this error.  
31 participants strongly agreed and two somewhat agreed that point of care testing 
for lactate should be continued; 22 participants strongly agreed and 13 somewhat 
agreed that point of care testing for lactate is useful in the Obstetrics and 
Gynaecology wards. Similarly, 24 participants strongly agreed and ten somewhat 
agreed that results from point of care lactate devices would influence the 
management of their patients and 30 participants strongly agreed and three 
somewhat agreed that lactate testing is useful in the HDU to monitor sick patients 
(Table 1).  
29 participants strongly agreed and four somewhat agreed that creatinine testing 
should be continued whilst 26 participants strongly agreed and seven somewhat 
agreed that it is useful. 28 participants strongly agreed and six somewhat agreed 
that creatinine analysis would influence patient management. Creatinine can be 
analysed by the hospital laboratory; nevertheless, 23 participants strongly agreed 
and three somewhat agreed that creatinine analysis by point of care testing is 
preferable to its analysis by the hospital laboratory (Table 2).  
26 participants strongly agreed and seven somewhat agreed that point of care 
testing would improve efficiency in the Obstetrics and Gynaecology wards. Most 
staff trusted the results from point of care meters but only 20 participants strongly 
agreed and nine somewhat agreed to this (Table 3).  
Quality control checks were consistently within their normal ranges. Owing to power 
outages there were a few interruptions in refrigerator power; however, these were 
of short duration and were unlikely to have adversely affected the creatinine test 
strips. Inadequate documentation of test and failure to recognise abnormal test 
results was not observed during this pilot study. 
Many members of staff commented favourably on how the meters aided patient 
care (“I think it helps make critical decisions quickly” – registrar) and asked for 
continuation of the study (“Please continue supplying us with testing kits for 
continuation of testing” – nurse-midwife; “As long as sustainability is maintained 
these are very good bedside tests” – intern).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The findings suggest that point of care testing for both lactate and creatinine is 
considered helpful for clinical care and is favoured by staff in the obstetric unit. Point 
of care testing for lactate was considered most beneficial for use in the HDU for 
regular monitoring of sick patients to guide clinicians on a patient’s progress or to 
alert them to deterioration. The availability of hand-held meters for this purpose 
considerably enhanced the availability and feasibility of lactate measurements, 
meaning that lactate could be used as a dynamic marker for risk stratification of 
critically ill patients in the obstetric HDU. A recent study confirmed that dynamic 
indices of lactate are superior predictors of mortality than static indices, since they 
describe not only the magnitude but also the trend of hyperlactataemia over time 
(11) (12). Nevertheless, static lactate indices also have an important role, for 
example in guiding clinical decisions as to who should be admitted to a high 
dependency model of care. Such decisions may have profound implications not only 
on patient wellbeing but also on the appropriate use of scarce resources by using 
available beds, staff time and investigations for those most able to benefit. Thus, 
point of care testing can facilitate the effective use of a limited number of HDU beds 
with high occupancy and accelerate the smooth ”step up” care for patients who 
deteriorate and “step down” care for those ready to transfer to a postnatal ward 
(13).  
Whilst it was beyond the scope of this feasibility study to formally investigate point 
of care testing in relation to patient outcomes or to define its cost-effectiveness, 
evidence from a study in emergency department patients with suspected sepsis 
suggest that the introduction of point of care lactate devices reduces the time to 
administration of intravenous fluids, Intensive Care Unit admission where needed 
and indeed mortality (14). Routine implementation of point of care testing in 
emergency departments of low and middle-income countries has been reported to 
be associated with improved health-related outcomes and can be cost effective (15). 
Given the considerable burden of sepsis in referred obstetric patients, these results 
are likely to be transferable to specialist obstetric units in low resource settings.  
We noted that trust in the results of point of care devices was relatively low, with 
just over half of participants strongly agreeing that they trust the results. Studies 
have reported a close correlation in measurements between point of care devices 
and a reference standard laboratory analyser for both lactate (16) (17) and 
creatinine (18) (19) (20) but for staff to gain confidence in the results, an 
implementation strategy would need to include an initial component of validation of 
findings against results from an appropriate reference laboratory. 
The present study was not designed to assess the influence of access to these tests 
to clinical decision making, outcomes and cost-effectiveness and the next stage will 
be to design appropriate implementation research to generate this knowledge, 
initially in large referral facilities such as the QECH before consideration is given to 
extending the approach to District level facilities. 
We conclude that implementation of point of care testing in the Department of 
Obstetrics and Gynaecology at QECH is worthwhile and staff felt strongly that the 
point of care consumables should be available for future continuation of point of 
care testing – “Let it continue” (nurse-midwife).  
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HDU – High dependency unit 
MMR – maternal mortality ratio 
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  Staff group Strongly 
disagree 
Somewhat 
disagree 
Neither 
agree or 
disagree 
Somewhat 
agree 
Strongly 
agree 
Don’t 
know 
No response 
POC testing for lactate 
should be continued in the 
Obstetrics and 
Gynaecology wards 
Nurse-midwives 0 0 0 1 (4.5) 19 (86) 1 (5) 1 (5) 
Clinicians 1 (7) 0 1 (7) 1 (7) 12 (80) 0 0 
Total 1 (3) 0 1 (3) 2 (5) 31 (83) 1 (3) 1 (3) 
POC testing for lactate is 
useful in the Obstetrics 
and Gynaecology wards 
Nurse-midwives 0 0 0 8 (36) 13 (59) 1 (4.5) 0 
Clinicians 1 (7) 0 0 5 (33) 9 (60) 0 0 
Total 1 (3) 0 0 13 (35) 22 (59) 1 (3) 0 
POC testing for lactate 
would influence the 
management of my 
patients 
Nurse-midwives 0 0 0 4 (18) 16 (72) 1 (5) 1 (5) 
Clinicians 1 (7) 0 0 6 (40) 7 (46) 0 1 (7) 
Total 1 (3) 0 0 10 (27) 24 (64) 1 (3) 1 (3) 
POC testing for lactate 
would be useful for 
monitoring sick patients in 
HDU 
Nurse-midwives 0 0 0 1 (5) 17 (77)  2 (9) 2 (9) 
Clinicians 0 0 0 2 (13) 13 (87) 0 0 
Total 0 0 0 3 (8) 30 (82)  2 (5) 2 (5) 
Table 1. Questionnaire results of staff members regarding their opinion on the use of lactate in the Obstetrics and Gynaecology wards at QECH. Results are displayed as 
number of participants (percentage). POC – point of care 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Table 2. Questionnaire results of staff members regarding their opinion on the use of creatinine in the Obstetrics and Gynaecology wards at QECH. Results are displayed as 
number of participants (percentage). POC – point of care 
 
 
 Staff group Strongly 
disagree 
Somewhat 
disagree 
Neither 
agree or 
disagree 
Somewhat 
agree 
Strongly 
agree 
Don’t 
know 
No response 
POC testing for creatinine 
should be continued in the 
Obstetrics and 
Gynaecology wards 
Nurse-midwives 0 0 0 3 (14) 16 (72) 0 3 (14) 
Clinicians 1 (7) 0 0 1 (7) 13 (86) 0 0 
Total 1 (3) 0 0 4 (11) 29 (78) 0 3 (8) 
POC testing for creatinine 
is useful in the Obstetrics 
and Gynaecology wards 
Nurse-midwives 0 0 0 6 (27) 13 (59) 0 3 (14) 
Clinicians 1 (7) 0 0 1 (7) 13 (86) 0 0 
Total 1 (3) 0 0 7 (19) 26 (70) 0 3 (8) 
POC testing for creatinine 
would influence the 
management of my 
patients 
Nurse-midwives 0 0 0 5 (23) 15 (68) 0 2 (9) 
Clinicians 1 (7) 0 0 1 (7) 13 (86) 0 0 
Total 1 (3) 0 0 6 (16) 28 (76) 0 2 (5) 
POC testing for creatinine 
is preferable to analysis by 
the hospital laboratory 
Nurse-midwives 1 (5) 1 (5) 0 2 (9) 14 (64) 0 4 (18) 
Clinicians 0 2 (13) 1 (7) 1 (7) 9 (60) 2 (13) 0 
Total 1 (3) 3 (8) 1 (3) 3 (8) 23 (62) 2 (5) 4 (11) 
  
 
 
 Staff group Strongly 
disagree 
Somewhat 
disagree 
Neither 
agree or 
disagree 
Somewhat 
agree 
Strongly 
agree 
Don’t 
know 
No response 
POC testing for would 
improve efficiency in the 
Obstetrics and 
Gynaecology wards 
Nurse-midwives 0 0 0 4 (18) 15 (68) 0 3 (14) 
Clinicians 1 (7) 0 0 3 (20) 11 (73) 0 0 
Total 1 (3) 0 0 7 (18) 26 (73) 0 3 (8) 
I trust the results of point 
of care devices 
Nurse-midwives 0 0 2 (9) 3 (14) 13 (59) 1 (5) 3 (14) 
Clinicians 0 0 1 (7) 6 (40) 7 (47) 0 1 (7) 
Total 0 0 3 (8) 9 (24) 20 (54) 1 (3) 4 (11) 
Table 3. Questionnaire results of staff members regarding their opinion the use of point of care testing in the Obstetrics and Gynaecology wards at QECH. Results are 
displayed as number of participants (percentage). POC – point of care 
 
 
 
 
 
 
